Parsons J T, Mendenhall W M, Stringer S P, Cassisi N J, Million R R
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, USA.
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):605-9. doi: 10.1016/0360-3016(95)00527-6.
We analyzed the clinical course of patients who developed local (primary) recurrence following high-dose irradiation of squamous cell carcinoma of the supraglottic larynx.
Between October 1964 and July 1991, 206 patients with previously untreated squamous cell carcinoma of the supraglottic larynx underwent radiotherapy with curative intent. Local failure occurred in 46 (22%) patients. Successful surgical salvage was defined as no evidence of recurrent cancer for at least 2 years after salvage surgery and continuously thereafter.
Sixteen patients did not undergo salvage surgery because of refusal (7 patients), severe medical illness (2 patients), concurrent distant metastasis (5 patients), or unresectable neck disease (2 patients). Twenty-six patients underwent total laryngectomy, and 4 patients had a voice-sparing procedure. Successful salvage was achieved in 50% of patients who underwent surgery. The rate of successful salvage did not correlate with preirradiation T-stage or time to failure after irradiation. Most of the failures after surgery were because of failure to control the primary cancer. The overall rate of postsurgical complications was 37%. No operative or perioperative deaths occurred. The 5-year survival rate for all 46 patients, calculated from the date of irradiation failure, was 20%, while the 5-year survival rate after salvage surgery for the 30 patients who underwent the procedure was 29%.
There are few data in the literature regarding the clinical outcome in patients whose tumors are not controlled by initial radiotherapy. In the current and previous series, one-half to two-thirds of patients who developed primary failure underwent salvage surgery, which was successful in approximately half of the operated patients, leading to a 25-30% rate of long-term disease-free survival among the entire group of patients who developed failure.
我们分析了声门上型喉鳞状细胞癌大剂量放疗后发生局部(原发性)复发患者的临床病程。
1964年10月至1991年7月,206例未经治疗的声门上型喉鳞状细胞癌患者接受了根治性放疗。46例(22%)患者出现局部失败。成功的挽救性手术定义为挽救性手术后至少2年无复发癌证据,且此后持续无复发。
16例患者因拒绝(7例)、严重内科疾病(2例)、同时发生远处转移(5例)或颈部疾病无法切除(2例)而未接受挽救性手术。26例患者接受了全喉切除术,4例患者接受了保留发音功能的手术。接受手术的患者中有50%实现了成功挽救。成功挽救率与放疗前T分期或放疗后失败时间无关。手术后的大多数失败是由于未能控制原发性癌症。手术后并发症的总体发生率为37%。无手术或围手术期死亡。从放疗失败日期算起,所有46例患者的5年生存率为20%,而接受该手术的30例患者挽救性手术后的5年生存率为29%。
关于初始放疗未能控制肿瘤的患者的临床结局,文献中的数据很少。在本系列和之前的系列中,发生原发性失败的患者中有一半至三分之二接受了挽救性手术,其中约一半的手术患者获得成功,导致整个失败患者组的长期无病生存率为25%至30%。